Literature DB >> 369587

Serological response to intracaecal injections of antigenic mouse tumour cells.

M L Laursen.   

Abstract

Immunofluorescence studies of sera from mice with induced enhancement of tumour growth demonstrated that these sera contained factors ("interfering factors") which in an apparently competitive manner interfered with the subsequent binding of specific antibodies to antigenic sites on the tumour-cell membrane. The factors were tumour-specific but lacked some of the immunoglobulin determinants. They could not be detected by polyvalent FITC-antimouse gamma-globulin. Interfering factors did not seem to be related to IgA or IgE. They were demonstrable in sera from tumour-free animals without growing tumours, thus differing from the tumour-specific "blocking factors".

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 369587      PMCID: PMC2009818          DOI: 10.1038/bjc.1978.274

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  ANTIGENIC PROPERTIES OF LYMPHOMAS INDUCED BY THE MOLONEY AGENT.

Authors:  E KLEIN; G KLEIN
Journal:  J Natl Cancer Inst       Date:  1964-03       Impact factor: 13.506

2.  Immunological enhancement of tumor homografts in mice: a review.

Authors:  N KALISS
Journal:  Cancer Res       Date:  1958-10       Impact factor: 12.701

3.  Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Nat New Biol       Date:  1972-08-09

4.  Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status.

Authors:  R W Baldwin; M J Embleton; R A Robins
Journal:  Int J Cancer       Date:  1973-01-15       Impact factor: 7.396

5.  Humoral antibody in allograft reactions.

Authors:  H J Winn
Journal:  Transplant Proc       Date:  1970-03       Impact factor: 1.066

6.  The role of blocking antibodies in immunological enhancement.

Authors:  M Takasugi; E Klein
Journal:  Immunology       Date:  1971-10       Impact factor: 7.397

Review 7.  Specific blocking factors--are they important?

Authors:  K E Hellström; I Hellström; J T Nepom
Journal:  Biochim Biophys Acta       Date:  1977-12-23

8.  Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

Authors:  H O Sjögren; I Hellström; S C Bansal; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

9.  Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.

Authors:  G A Currie; C Basham
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640

10.  Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route.

Authors:  M L Laursen; K Laursen
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

View more
  3 in total

1.  Dependence on antigen dose and timing in the immune response of C3H mice to malignant ascites cells.

Authors:  M L Laursen; K Laursen
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

2.  Is cyclophosphamide self-defeating as an antitumor agents?

Authors:  M L Laursen
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

3.  Immunological enhancement induced by gastrointestinal immunization of mice pretreated with cyclophosphamide.

Authors:  M L Laursen
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.